Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Franz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Urologie (Heidelberg, Germany)|June 9, 2023
[Precision oncology options in urological cancers]Antonia Franz, Henning Plage, Annika Fendler, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2018
Circular RNAs: a new class of biomarkers as a rising interest in laboratory medicineAntonia Franz, Anja Rabien, Carsten Stephan, et al.
Theranostics|August 18, 2020
Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to realityHannah Rochow, Antonia Franz, Monika Jung, et al.
Cancers|October 3, 2019
Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic AccuracyAntonia Franz, Bernhard Ralla, Sabine Weickmann, et al.
International Journal of Molecular Sciences|October 27, 2020
Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological FactorsHannah Rochow, Monika Jung, Sabine Weickmann, et al.
BMC Urology|April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitorsHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
International Urology and Nephrology|October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladderKrystian Kaczmarek, Henning Plage, Kira Furlano, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
Cancer Discovery|January 9, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cancer Discovery|January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Urologie (Heidelberg, Germany)|June 9, 2023
[Precision oncology options in urological cancers]Antonia Franz, Henning Plage, Annika Fendler, et al.
Clinical Chemistry and Laboratory Medicine|May 28, 2018
Circular RNAs: a new class of biomarkers as a rising interest in laboratory medicineAntonia Franz, Anja Rabien, Carsten Stephan, et al.
Theranostics|August 18, 2020
Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to realityHannah Rochow, Antonia Franz, Monika Jung, et al.
Cancers|October 3, 2019
Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic AccuracyAntonia Franz, Bernhard Ralla, Sabine Weickmann, et al.
International Journal of Molecular Sciences|October 27, 2020
Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological FactorsHannah Rochow, Monika Jung, Sabine Weickmann, et al.
BMC Urology|April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitorsHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
International Urology and Nephrology|October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladderKrystian Kaczmarek, Henning Plage, Kira Furlano, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
Cancer Discovery|January 9, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cancer Discovery|January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Pageof 1